Breast Cancer: Targets and Therapy
Volume 14, 2022 - Issue
Open access
352
Views
1
CrossRef citations to date
0
Altmetric
Review
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection
Maria Chiara Parati1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy
, Rebecca Pedersini2 Breast Unit-Medical Oncology, ASST Spedali Civili, Brescia, Italy
, Gianluca Perego3 Pharmacy Unit, IRCCS San Raffaele Hospital, Milan, Italy
https://orcid.org/0000-0002-4309-4946
Roberto Reduzzi4 Breast Unit, ASST Bergamo Ovest, Treviglio, BG, Italy
, Tommaso Savio4 Breast Unit, ASST Bergamo Ovest, Treviglio, BG, Italy
, Mary Cabiddu1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy
, Karen Borgonovo1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy
, Mara Ghilardi1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy
, Andrea Luciani1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy
& Fausto Petrelli1 Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-9639-4486
Pages 101-111
|
Published online: 12 Apr 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.